Joel Pitz
Analyst · Joel Hurwitz with Dowling & Partners
Thanks, Deanna. Good morning to everyone on the call. I'll walk through our financial performance for the fourth quarter and full year, provide updates on our investment portfolio and capital position and share details of our outlook for 2025. As shown on Slides 3 and 4, excluding significant variances, full year non-GAAP operating earnings were $1.8 billion or $7.65 per diluted share. This represents an 11% increase in EPS over 2023, comfortably within our 9% to 12% EPS guidance. Results for the quarter were equally strong, with non-GAAP operating earnings excluding significant variances of $485 million or $2.10 per diluted share, a 16% increase over the year ago quarter. You can find the significant variance items on Slide 17 through 19. Full year reported net income excluding exited business was $1.5 billion, with modest credit losses and drift, both slightly better than our expectations at the beginning of the year. Non-GAAP operating ROE for 2024 excluding our actuarial assumption review was 13.7%, an improvement of 90 basis points compared to the year ago period. We remain on track to deliver our 14% to 16% targeted ROE by 2025. 2024 equity markets created favorable tailwinds with strong total returns across major indices. The S&P 500 gained 25% for the year, with more modest growth in small cap, mid-cap, real estate and international equities. Our diversified equity asset mix, along with our allocation to fixed income asset classes, results in market performance that varies from the S&P 500. This underscores the importance of recognizing the asset mix within our AUM, which can be found in the Appendix on Slide 16. Foreign exchange rates negatively impacted AUM by $28 billion for the full year and $17 billion for the quarter. Despite this impact, equity market performance more than offset the FX impacts for the full year. The following commentary excludes significant variances. Our full year results demonstrate the strength of our integrated businesses, which enabled us to deliver on our 2024 enterprise guidance of 9% to 12% EPS growth. We delivered top line growth of 5% across the company in 2024. This, coupled with expense discipline while investing in our business, resulted in non-GAAP margin expansion of 60 basis points during the year. Starting with RIS, full year pretax operating earnings increased 9% over 2023, driven by strong business growth, favorable market conditions and higher net investment income. Net revenue growth of 7% for the full year exceeded our long-term target and our guidance for 2024. The 40% margin was at the high end of our guided range. These results highlight our disciplined focus on profitable revenue growth, supported by favorable macroeconomic tailwinds. Principal Asset Management delivered strong results for the year. Specifically, investment management's pretax operating earnings increased 6% over 2023, driven by higher management fees resulting from strong market performance. Full year operating margin of 35% expanded 100 basis points from a year ago, a noteworthy accomplishment in a year with limited contributions from performance fees. International pensions pretax operating earnings were relatively flat compared to 2023 due to $26 million of FX impacts in the year. On a constant currency basis, earnings increased 9%, driven by 4% growth in net revenue. Operating margin improved by 100 basis points, reflecting growth and strong execution in our targeted markets. Although we revised the presentation, it is worth noting that PGI delivered on full year guidance, as did Principal International on a constant currency basis. Specialty Benefits continues to deliver attractive premium and fees growth, up 7% compared to full year 2023. Quarter-over-quarter comparisons are impacted by a large single premium sale in the fourth quarter of 2023, which makes direct comparisons less meaningful. Notably, Specialty Benefits produced record earnings in the fourth quarter as well as full year 2024. Loss ratio for the year of 60.4% was favorable and at the low end of our guided range. An operating margin of 15% was above the midpoint of our guided range. These results underscore the effectiveness of management actions to drive profitable growth. In our Life business, growth in our business market continues to outpace the roll-off of the legacy block. Full year life premium and fees increased 1% overall, with business market premium and fees up 16% year-over-year. We executed another YRT reinsurance transaction as we continue to derisk the legacy Life portfolio. This had an immaterial impact on earnings and a slight decrease to premium and fees. Excluding the 2024 reinsurance transactions, premium and fees growth was 3% in 2024. Turning to our investment portfolio. We maintain a well-diversified and high-quality portfolio that aligns with our liability profile, is well positioned to perform across a variety of economic conditions. While commercial mortgage loans may still be on some investors' minds, our portfolio is of high quality. With an average loan-to-value ratio of 50% and debt service coverage ratio of 2.3x, we continue to re-underwrite our office loans each quarter. After successfully resolving our 2024 office loan maturities, we entered 2025 with continued optimism. Maturities in the coming year are lower than in 2024 at $310 million. We are off to a good start, with $75 million already having been paid off. [ Revital ] and capital market activity will help the office market continue its recovery path. For more detailed information, we have provided supplemental investment slides available on our website. Turning to capital and liquidity. We ended the year in a very strong position, with $1.6 billion of excess and available capital. This includes $830 million at the holding company, above our $800 million targeted level, $300 million in our subsidiaries, and $430 million in excess of our targeted 375% risk-based capital ratio, which is 404% at year-end. On a full year basis, we delivered 80% free capital flow conversion, comfortably within our 75% to 85% targeted range. As shown on Slide 3, we returned $1.7 billion to shareholders in 2024, including $1 billion via share repurchases and $660 million in common stock dividends. As Deanna noted previously, this was above the midpoint of our 2024 guidance. This included just under $470 million of capital returned to shareholders in the fourth quarter, $300 million in share repurchases and $170 million in dividends. Last night, we announced a $0.75 common stock dividend, payable in the first quarter. This represents a $0.02 increase over the prior quarter's dividend, a 10% dividend growth rate on a trailing 12-month basis and aligns with our targeted 40% dividend payout ratio, underscoring our confidence in continued growth and strong performance. Our results reinforce our balanced approach to capital deployment, creating long-term value for shareholders while maintaining financial flexibility to support growth opportunities. Turning to our outlook, starting on Slide 11. We are well positioned to deliver on our enterprise long-term financial targets again in 2025. These were reaffirmed at Investor Day, with 9% to 12% growth in earnings per share, 75% to 85% free capital flow conversion and 14% to 16% return on equity. As a reminder, these targets are excluding significant variances. We expect to see even stronger EPS growth on a reported basis. We remain committed to returning excess capital to shareholders and are targeting $1.4 billion to $1.7 billion of capital deployments in 2025. This includes $700 million to $1 billion of share repurchases and a 40% dividend payout ratio. Our guidance assumes run rate variable investment income, or VII. We will continue to quantify the impact to reported results from higher lower-than-expected VII and a significant variance in our earnings cost throughout the year. For 2025, we expect VII to improve compared to 2024. Turning to our business units. Slide 12 outlines our 2025 enterprise outlook, medium-term business unit expectations for 2025 through 2027 and modeling considerations for 2025. Business unit guidance assumes normal market conditions. Taken together, this guidance reinforces our confidence in the sustained delivery of our financial targets at the enterprise level. In RIS, building on the strong results in 2024, we are revising our margin guidance upward, and net revenue guidance of 2% to 5% remains intact. In investment management, medium-term guidance reflects the underlying strength of our global asset management business. We expect revenue growth and margin to be within these ranges in 2025. In international pension, our guidance looks different from what we showed in the past for Principal International due to the resegmentation and the change in the net revenue metric to better align with the rest of the enterprise. We expect net revenue to be at the midpoint of the range on a constant currency basis, but below the range on a reported basis due to the strengthening of the U.S. dollar relative to last year. Margin is expected to improve from 2024 levels, be at the low end of the range in 2025 and improving thereafter. In Specialty Benefits, the dental market was dynamic during 2024. We maintained our underwriting discipline, resulting in lower sales in the second half of the year. As a result, we are revising our medium-term premium fees guidance to 6% to 9%, which remains above industry growth. In 2025, we expect growth to be near the low end of this range, with growth improving throughout the year. The ongoing discipline in underwriting is contributing to continued strength in our block, leading us to improve our loss ratio and margin targets, reflecting confidence in the overall business fundamentals and health of this business. In Life, premium fees growth is expected to be at or above the high end of the range for the year, with high-teens growth in our business market block, partially offset by the runoff of our legacy block. Our revised margin guidance reflects improvement over 2024. Before opening for questions, I want to remind you of a few seasonality impacts. In Investment Management, the first quarter is typically our lowest quarter for earnings due to the seasonality of deferred compensation and elevated payroll taxes. Specifically, we expect approximately $40 million of seasonally higher expenses in the first quarter with no impact to full year outlook. In Specialty Benefits, dental claims are typically higher in the first half of the year. Similar to the pattern in 2024, these factors will contribute to earnings being meaningfully higher in the second half than the first half of 2025. Additionally, they drive the seasonal pattern of free capital flow, which is typically lightest in the first half of the year and increases in the second half. We have good momentum as we start 2025 with a strong capital position, and we are well positioned to deliver on our long-term financial targets. We are grounded in our growth drivers of the retirement ecosystem, small and midsized businesses and global asset management while continuing to drive long-term shareholder value. This concludes our prepared remarks. Operator, please open the call for questions.